Skip to content
    Inve.money
    Earnings calls

    Bodal Chemicals Limited concall ledger

    Every earnings call for BODALCHEM — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    BODALCHEM · 3 transcripts · Chemicals · latest Q1 FY26

    Bodal Chemicals Limited has 3 earnings calls on record here, a Chemicals company, most recently Q1 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.

    Q1 FY26Published 12 Aug 2025Call held 12 Aug 2025

    BODALCHEM Q1 FY26 Earnings Call Transcript & Analysis

    Consolidated Revenue₹458 cr+8% YoYConsolidated EBITDA₹52 cr+40% YoYConsolidated EBITDA Margin11.3%Consolidated PAT₹9.53 cr

    Consolidated Revenue ₹458 cr (+8% YoY); Consolidated EBITDA ₹52 cr (+40% YoY); Consolidated EBITDA Margin 11.3%. Consolidated revenue reached ₹458 crores, an 8% increase YoY.

    Read full transcript & analysis
    Q4 FY25Published 29 May 2025Call held 29 May 2025

    BODALCHEM Q4 FY25 Earnings Call Transcript & Analysis

    Consolidated Revenue₹453 cr+14% YoYConsolidated EBITDA₹50 cr+62% YoYConsolidated EBITDA Margin10.9%Consolidated PAT₹14.5 cr

    Consolidated Revenue ₹453 cr (+14% YoY); Consolidated EBITDA ₹50 cr (+62% YoY); Consolidated EBITDA Margin 10.9%. Consolidated Q4 FY25 Revenue up 14% YoY to ₹453 crores.

    Read full transcript & analysis
    Q3 FY25Published 13 Feb 2025Call held 13 Feb 2025

    BODALCHEM Q3 FY25 Earnings Call Transcript & Analysis

    Consolidated Revenue₹446 cr+30% YoYConsolidated EBITDA₹46 cr+63% YoYConsolidated EBITDA Margin10.4%Consolidated PAT₹5 cr

    Consolidated Revenue ₹446 cr (+30% YoY); Consolidated EBITDA ₹46 cr (+63% YoY); Consolidated EBITDA Margin 10.4%. Consolidated revenue for Q3 FY25 grew 30% YoY to Rs. 446 crores.

    Read full transcript & analysis